Irvin Winkler

1.0k total citations
41 papers, 870 citations indexed

About

Irvin Winkler is a scholar working on Molecular Biology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Irvin Winkler has authored 41 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Infectious Diseases and 9 papers in Pharmacology. Recurrent topics in Irvin Winkler's work include HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (9 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). Irvin Winkler is often cited by papers focused on HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (9 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). Irvin Winkler collaborates with scholars based in Germany, United States and Belgium. Irvin Winkler's co-authors include G Riess, Manfred Rösner, Gerhard Seibert, M. Limbert, Arno Paessens, J P Kleim, E. Schrinner, Eddy Arnold, Y. Hsiou and N. Klesel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Molecular Biology and Journal of Medicinal Chemistry.

In The Last Decade

Irvin Winkler

39 papers receiving 796 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Irvin Winkler Germany	18	375	318	251	197	155	41	870
Hsu‐Tso Ho United States	15	370 1.0×	250 0.8×	326 1.3×	120 0.6×	293 1.9×	17	935
David Orr Germany	14	275 0.7×	132 0.4×	257 1.0×	170 0.9×	98 0.6×	21	727
Aesop Cho United States	15	450 1.2×	63 0.2×	326 1.3×	254 1.3×	168 1.1×	24	906
Véronique Joly France	20	699 1.9×	390 1.2×	143 0.6×	251 1.3×	48 0.3×	63	1.0k
Ekachai Jenwitheesuk Thailand	14	280 0.7×	137 0.4×	254 1.0×	97 0.5×	51 0.3×	24	728
Ron M. Kagan United States	20	647 1.7×	512 1.6×	554 2.2×	162 0.8×	52 0.3×	44	1.3k
Ilaria Frasson Italy	22	134 0.4×	71 0.2×	919 3.7×	313 1.6×	59 0.4×	37	1.5k
Anne Goh Singapore	11	374 1.0×	31 0.1×	289 1.2×	214 1.1×	106 0.7×	11	803
Akira Shishido Japan	20	171 0.5×	86 0.3×	397 1.6×	288 1.5×	77 0.5×	89	1.2k
Vimal K. Maurya India	12	424 1.1×	129 0.4×	250 1.0×	108 0.5×	24 0.2×	26	877

Countries citing papers authored by Irvin Winkler

Since Specialization

Citations

This map shows the geographic impact of Irvin Winkler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irvin Winkler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irvin Winkler more than expected).

Fields of papers citing papers by Irvin Winkler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irvin Winkler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irvin Winkler. The network helps show where Irvin Winkler may publish in the future.

Co-authorship network of co-authors of Irvin Winkler

This figure shows the co-authorship network connecting the top 25 collaborators of Irvin Winkler. A scholar is included among the top collaborators of Irvin Winkler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irvin Winkler. Irvin Winkler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hurst, W. Jeffrey, Etienne Guillot, Werngard Czechtizky, et al.. (2013). Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (Part II). Bioorganic & Medicinal Chemistry Letters. 23(11). 3421–3426. 5 indexed citations

Winkler, Irvin, et al.. (2010). Pseudo Vitamin D Deficiency Rickets in Pigs: In vitro Measurements of Renal 25-Hydroxycholecalciferol-1-hydroxylase Activity. Zentralblatt für Veterinärmedizin Reihe A. 29(2). 81–88.

Herzog, P, et al.. (2008). Chryseobacterium ureilyticum sp. nov., Chryseobacterium gambrini sp. nov., Chryseobacterium pallidum sp. nov. and Chryseobacterium molle sp. nov., isolated from beer-bottling plants. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY. 58(1). 26–33. 63 indexed citations

Kleim, Jőrg‐Peter, et al.. (1999). Antiviral Activity of the Human Immunodeficiency Virus Type 1–Specific Nonnucleoside Reverse Transcriptase Inhibitor HBY 097 Alone and in Combination with Zidovudine in a Phase II Study. The Journal of Infectious Diseases. 179(3). 709–713. 11 indexed citations

Balzarini, Jan, et al.. (1998). Retention of marked sensitivity to (S)-4-isopropoxycarbonyl-6-methoxy-3-(methylthiomethyl)-3,4-Dihydroquinoxaline-2(1H)-Thione (HBY 097) by an azidothymidine (AZT)-resistant human immunodeficiency virus type 1 (HIV-1) strain subcultured in the combined presence of quinoxaline HBY 097 and 2′,3′-dideoxy-3′-thiacytidine (Lamivudine). Biochemical Pharmacology. 55(5). 617–625. 9 indexed citations

Hsiou, Y., Kalyan Das, Jianping Ding, et al.. (1998). Structures of Tyr188Leu mutant and wild-type HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor HBY 097: inhibitor flexibility is a useful design feature for reducing drug resistance 1 1Edited by J. Karn. Journal of Molecular Biology. 284(2). 313–323. 107 indexed citations

Winkler, Irvin, Manfred Rösner, Reinhard Kirsch, et al.. (1997). In VitroSelection for Different Mutational Patterns in the HIV-1 Reverse Transcriptase Using High and Low Selective Pressure of the Nonnucleoside Reverse Transcriptase Inhibitor HBY 097. Virology. 231(1). 112–118. 30 indexed citations

Balzarini, Jan, Heidi Pelemans, G Riess, et al.. (1997). Zidovudine‐Resistant Human Immunodeficiency Virus Type 1 Strains Subcultured in the Presence of Both Lamivudine and Quinoxaline HBY 097 Retain Marked Sensitivity to HBY 097 but Not to Lamivudine. The Journal of Infectious Diseases. 176(5). 1392–1397. 12 indexed citations

Kleim, J P, Manfred Rösner, Irvin Winkler, et al.. (1996). Selective pressure of a quinoxaline nonnucleoside inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) on HIV-1 replication results in the emergence of nucleoside RT-inhibitor-specific (RT Leu-74-->Val or Ile and Val-75-->Leu or Ile) HIV-1 mutants.. Proceedings of the National Academy of Sciences. 93(1). 34–38. 76 indexed citations

10.

Müller, A., et al.. (1994). Regioselective Synthesis and Antiviral Activity of Purine Nucleoside Analogues with Acyclic Substituents at N7. Angewandte Chemie International Edition in English. 33(5). 562–563. 30 indexed citations

11.

Limbert, M., Gerhard Seibert, Irvin Winkler, et al.. (1992). Antibacterial activity in vitro of cefpirome against clinical isolates causing sexually transmitted diseases. Journal of Antimicrobial Chemotherapy. 29(suppl A). 13–17. 4 indexed citations

12.

Müller, A., et al.. (1992). Preparation of carbocyclic phosphonate nucleosides. Tetrahedron Letters. 33(37). 5335–5338. 20 indexed citations

13.

Müller, Wernér E.G., et al.. (1990). Polyclonal antibodies to mannan from yeast also recognize the carbohydrate structure of gp120 of the AIDS virus. AIDS. 4(2). 159–162. 24 indexed citations

14.

Winkler, Irvin, et al.. (1988). New prodrugs of acyclic nucleosides with antiviral activity.. PubMed. 38(11). 1545–8. 4 indexed citations

15.

Winkler, Irvin, et al.. (1986). Absence of renal 25-hydroxycholecalciferol-1-hydroxylase activity in a pig strain with vitamin D-dependent rickets. Calcified Tissue International. 38(2). 87–94. 24 indexed citations

16.

Klesel, N., M. Limbert, Gerhard Seibert, Irvin Winkler, & E. Schrinner. (1986). Chemotherapeutic effects of ofloxacin (HOE 280) and other quinolone-carboxylic derivates in the treatment of experimental lung infections due to Klebsiella pneumoniae DT-S in mice. Infection. 14(S1). S36–S39. 7 indexed citations

17.

Winkler, Irvin, et al.. (1984). Macromolecular changes during oogenesis of Formica polyctena (Foerster) (Ins., Hym., Form.): A case of two types of eggs differently predisposed. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 78(4). 827–837. 2 indexed citations

18.

Klesel, N., M. Limbert, Gerhard Seibert, Irvin Winkler, & E. Schrinner. (1984). Cefodizime, an aminothiazolyl cephalosporin. III. Therapeutic activity against experimentally induced pneumonia in mice.. The Journal of Antibiotics. 37(12). 1712–1718. 21 indexed citations

19.

Klesel, N., M. Limbert, K. Seeger, et al.. (1984). Cefodizime, an aminothiazolylcephalosporin. II. Comparative studies on the pharmacokinetic behavior in laboratory animals.. The Journal of Antibiotics. 37(8). 901–909. 21 indexed citations

20.

Winkler, Irvin, et al.. (1959). A preliminary study of the use of 2-methyl-1, 2-bis (3-pyridyl)-1-propanone (SU 4885) as a test of pituitary function in man.. PubMed. 59. 3596–608. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact